[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioTech Health X posts on X about launches, upside, $unh, $tnxp the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks finance currencies cryptocurrencies
Social topic influence launches, upside, $unh, $tnxp, longterm, $hca, $argx, $45b, momentum, $tars
Top assets mentioned UnitedHealth Group (UNH) HCA Healthcare Inc (HCA) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Fresenius Medical Care AG & Co. KGaA (FMS) Molina Healthcare, Inc. (MOH) Regeneron Pharmaceuticals Inc (REGN) Elevance Health Inc (ELV) Laboratory Corp. of America Holdings (LH) AstraZeneca PLC (AZN) Corcept Therapeutics Inc. (CORT) UPCX (UPC) 4 (4) Akropolis (AKRO) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
Top posts by engagements in the last XX hours
"$UNH @UnitedHealthGrp delivers $XXXXXX billion in revenue yet EPS falls short spotlighting margin challenges in a costly healthcare climate"
X Link @BioTechHealthX 2025-10-11T01:54Z XXX followers, XXX engagements
"$TNXP @TonixPharma shares fall despite FDA approval for Tonmya. Analysts say the sell-off could be a golden opportunity for long-term investors"
X Link @BioTechHealthX 2025-10-14T10:37Z XXX followers, XXX engagements
"$HCA @HCAhealthcare has soared from $XXX to over $XXX per share. With rising earnings estimates can HCA keep climbing higher"
X Link @BioTechHealthX 2025-08-26T14:34Z XXX followers, XXX engagements
"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"
X Link @BioTechHealthX 2025-10-09T10:46Z XXX followers, XX engagements
"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"
X Link @BioTechHealthX 2025-10-09T04:31Z XXX followers, XXX engagements
"$EBS Down from $1B in prior years @EmergentLabsHQ's trailing twelve-month revenue exposes how hard its recovery journey has become"
X Link @BioTechHealthX 2025-10-11T01:55Z XXX followers, XXX engagements
"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements
"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"
X Link @BioTechHealthX 2025-10-14T10:35Z XXX followers, XX engagements
"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"
X Link @BioTechHealthX 2025-10-09T04:29Z XXX followers, XX engagements
"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"
X Link @BioTechHealthX 2025-10-13T18:30Z XXX followers, XXX engagements
"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"
X Link @BioTechHealthX 2025-10-09T04:32Z XXX followers, XX engagements
"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements
"$AZN @AstraZeneca eyes $80B in annual revenue by 2030 driven by XX new drug launches and booming oncology sales"
X Link @BioTechHealthX 2025-10-14T10:37Z XXX followers, XX engagements
"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"
X Link @BioTechHealthX 2025-10-01T05:23Z XXX followers, XX engagements
"$UPC Universe Pharmaceuticals shares skyrocketed XX% this week climbing from $X to $X amid speculation and strong volume. Is it a turnaround or another biotech bubble"
X Link @BioTechHealthX 2025-10-09T10:45Z XXX followers, XX engagements
"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"
X Link @BioTechHealthX 2025-10-14T10:36Z XXX followers, XX engagements
"$AXGN Revenue jumped XXXX% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to XX% upside before the December X ruling"
X Link @BioTechHealthX 2025-10-12T17:05Z XXX followers, XX engagements
"$NAMS NewAmsterdam Pharma rockets nearly XX% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib"
X Link @BioTechHealthX 2025-10-15T12:49Z XXX followers, XXX engagements